Insmed INSM Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $819.56M+35.1% | $606.42M+35.7% | $447.02M+12.3% | $398.11M+4.5% | $381.03M+4.8% | ||
| $149.08M+21.3% | $122.94M+17.2% | $104.87M+8.5% | $96.67M+7.9% | $89.56M+4.5% | ||
| $828M+7.4% | $771.09M+10.8% | $695.91M+5.4% | $660.3M+4.8% | $629.86M+5.3% | ||
| $800.88M+14.2% | $701.17M+11.1% | $631.2M+12.0% | $563.75M+9.3% | $515.56M+11.8% | ||
| $1.97B+6.4% | $1.85B+15.5% | $1.6B+14.4% | $1.4B+3.0% | $1.36B+9.7% | ||
| -$1.15B+7.6% | -$1.25B-7.7% | -$1.16B-15.2% | -$1B-2.4% | -$980.89M-11.7% | ||
| -140.6%+65.0pp | -205.6%+53.3pp | -258.9%-6.5pp | -252.4%+5.0pp | -257.4%-16.0pp | ||
| $82.31M-1.8% | $83.8M-1.1% | $84.75M-0.8% | $85.42M0.0% | $85.44M+0.6% | ||
| -$2.71M-47.1% | -$1.84M— | —— | —— | —— | ||
| -$1.18B+7.4% | -$1.27B-7.9% | -$1.18B-14.5% | -$1.03B-2.0% | -$1.01B-10.9% | ||
| $5.58M+11.0% | $5.03M+6.0% | $4.74M+6.9% | $4.44M+10.0% | $4.03M+8.7% | ||
| -$1.18B+7.3% | -$1.28B-7.9% | -$1.18B-14.5% | -$1.03B-2.1% | -$1.01B-10.9% | ||
| -144.4%+66.1pp | -210.5%+54.3pp | -264.8%-5.0pp | -259.8%+6.1pp | -265.9%-14.7pp | ||
| -$5.74+10.3% | -$6.40-3.7% | -$6.17-8.4% | -$5.69+4.0% | -$5.93-6.5% | ||
| -$1.13B+7.9% | -$1.23B-7.6% | -$1.14B-15.2% | -$992.5M-2.4% | -$969.58M-11.8% | ||
| -138.3%+64.6pp | -202.9%+53.0pp | -255.9%-6.6pp | -249.3%+5.2pp | -254.5%-16.0pp | ||
| -$1.15B+7.6% | -$1.25B-7.7% | -$1.16B-15.2% | -$1B-2.4% | -$980.89M-11.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Insmed's revenue?
- Insmed (INSM) generated $819.6M in revenue over the trailing twelve months, up 115.1% year over year.
- Is Insmed profitable?
- Insmed is not currently profitable: it reported a net loss of $1.2B over the trailing twelve months, a -144.4% net margin.
- What are Insmed's profit margins?
- Gross margin is 81.8% and operating margin is -140.6%, with a -144.4% net margin.
- What is Insmed's earnings per share?
- Insmed's diluted EPS over the trailing twelve months is $-5.74.
- Where does Insmed's income statement data come from?
- Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
